← Open Payments lookup

KATHLEEN COUGHLIN: Open Payments

NPI 1780222539 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$367 in 12 payments from 9 companies in 2025. Trend: 2023 $865 · 2024 $305 · 2025 $367

Food & beverage: $335Education: $32
CompanyPaymentsAmount
Alexion Pharmaceuticals, Inc.1$128
Celgene Corporation2$61
Novartis Pharmaceuticals Corporation2$48
Legend Biotech USA Inc.2$32
Incyte Corporation1$23
BeOne Medicines USA, Inc.1$23
Astellas Pharma US Inc1$20
Takeda Pharmaceuticals U.S.A., Inc.1$16
SANOFI-AVENTIS U.S. LLC1$16

Products named: BREYANZI, CARVYKTI, NIKTIMVO, BRUKINSA, Xtandi, Fabhalta, FRUZAQLA, REZUROCK.

Industry payments across MA — which companies pay providers there.